Start here if you're new
what it is
Lifetime Brands sells kitchen tools, dinnerware, and home goods under brands like Farberware and Mikasa.
how it gets paid
Last year Lifetime Brands made $648M in revenue. kitchenware was the main engine at $260M, or 40% of sales.
why growth slowed
Revenue fell 5.1% last year. Quarterly net sales were $204.1M, and gross margin reached 38.6% from 37.7%.
what just happened
Adjusted EPS came in at $1.05, far above the $0.29 estimate.
At a glance
C balance sheet — red flag territory — real financial stress
15/100 earnings predictability — expect surprises
4.5% dividend yield — cash in your pocket every quarter
0.6% return on capital — nothing to write home about
-$0.71 fy2024 eps est
xvary composite: 25/100 — weak
What they do
Lifetime Brands sells kitchen tools, dinnerware, and home goods under brands like Farberware and Mikasa.
VL lists 11 brands, including Farberware, KitchenAid, and Mikasa. You are not buying one product line. You are buying a shelf full of everyday items, and replacing them is annoying.
How they make money
$648M
annual revenue · their business grew -5.1% last year
kitchenware
$260M
home solutions
$160M
tableware
$155M
giftware and accessories
$73M
The products that matter
core housewares distribution
Kitchenware & Tableware
38.8% gross margin in the segment
this is the core business. sales fell, but gross margin rose to 38.8% from 37.6%. that spread is what management is trying to protect while volumes stay soft.
margin recovery
overseas housewares sales
International Business
$18.8M in Q4 2025
this segment fell 2.3% to $18.8M in the quarter. it is small enough that it will not rescue the company, but weak demand there still adds drag.
small contributor
licensed brand expansion
Dolly Parton line
2026 growth watch item
management pointed to the Dolly brand as a 2026 growth driver. the catch: there is no disclosed revenue figure here yet, so for now it is a narrative, not a model input.
watch, don't assume
Key numbers
$648M
annual revenue
That is the size of the whole business. You are buying a small company with a very real retail footprint.
4.5%
dividend yield
You get 4.5% cash back while you wait. That is a lot for a stock at $3.37.
7.7%
operating margin
This means 7.7 cents of operating profit per dollar of sales. That cushion is thin if freight or tariffs move against you.
73%
debt load
Debt is 73% of capital. That makes the balance sheet less forgiving if sales keep slipping.
Financial health
C
strength
- balance sheet grade C — very weak — significant financial distress
- risk rank 5 — safer than 5% of stocks
- price stability 15 / 100
- long-term debt $236M (73% of capital)
C — balance sheet grade and long-term debt are flagged. this stock carries more risk than average.
Total return vs. market
Return history isn't available for LCUT right now.
source: institutional data · return history unavailable
What just happened
beat estimates
Adjusted EPS came in at $1.05, far above the $0.29 estimate.
Quarterly net sales were $204.1M, and gross margin reached 38.6% from 37.7%. Lower ocean freight costs and a better product mix helped.
$204.1M
revenue
$1.05
eps
38.6%
gross margin
the number that mattered
Adjusted EPS of $1.05 beat the $0.29 estimate by $0.76. That is the whole story for the quarter.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is tariff pressure hitting a margin-led turnaround. LCUT just showed margin improvement on falling sales. That is a thin cushion if import costs move the wrong way.
med
Tariff pressure and sourcing cost inflation
Management cited extreme external disruption from tariffs as a core 2026 challenge. The recent earnings beat leaned on lower freight costs and better gross margin.
If sourcing costs rise, the 38.6% quarterly gross margin can give back ground fast. That would hit the part of the story the market just rewarded.
med
Material weakness in financial controls
A June 2024 SEC filing cited a material weakness in internal controls over financial reporting. That is not cosmetic for a company trying to rebuild trust.
Weak controls raise the odds of restatements, delayed filings, or more scrutiny. When the balance sheet is already stressed, credibility matters more.
med
Debt load limits flexibility
Long-term debt stands at $236M and represents 73% of total capital. The market cap is about $86M.
That mismatch means you are underwriting the lenders before you are underwriting growth. A weak quarter leaves less room to maneuver.
med
Acquisition risk on a weak base
Management said it is actively evaluating deals. That might sound opportunistic. It also might add complexity and debt before the current business is fully steady.
If a deal arrives before margins and controls are clearly repaired, the turnaround gets harder to trust and harder to model.
These risks all point at the same place: LCUT does not need perfection, but it does need the recent margin recovery to hold while debt stays contained.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
gross margin after the Q4 bounce
38.6% was the good news. If that slips back while revenue stays weak, the market will treat Q4 as a one-off.
calendar
Q1 2026 earnings and full-year outlook
Management is expected to give 2026 guidance with Q1 results in mid-May 2026. You want to see whether cost gains survive the new tariff backdrop.
risk
any sign of a debt-funded acquisition
The company is evaluating deals. With debt already at 73% of capital, more borrowing would change the story from turnaround to balance-sheet gamble.
trend
whether the Dolly Parton launch becomes revenue, not marketing
Management called this a growth driver for 2026. Until you see disclosed sales traction, treat it as an interesting test, not proof.
Analyst rankings
earnings predictability
15 / 100
in human-speak, analysts do not trust this company to deliver smooth quarters. you should expect surprises, and not all of them will be pleasant.
balance sheet grade
C
that grade points to a weak balance sheet. plain English: the turnaround has to work without much room for mistakes.
source: institutional data
Institutional activity
institutional ownership data for LCUT is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$3
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive